About 1,985,958 results (2,110 milliseconds)

Defining Survivorship in the Thyroid Cancer Space

https://news.google.com/__i/rss/rd/articles/CBMiUmh0dHBzOi8vd3d3LnRhcmdldGVkb25jLmNvbS92aWV3L2RlZmluaW5nLXN1cnZpdm9yc2hpcC1pbi10aGUtdGh5cm9pZC1jYW5jZXItc3BhY2XSAQA?oc=5
Jan 16, 2023 ... For a big pathology department like ours, we do about 80,000 cases a year, which means that there are hundreds of thousands if not millions of ...

In Silico Approach To Identify Potential Thyroid Hormone Disruptors ...

http://feedproxy.google.com/~r/acs/esthag/~3/IlzbVPIshFk/acs.est.5b01742
Jul 24, 2015 ... ... disease and depression in later life stages.(6, 7). One of the molecular targets of THDCs is the thyroid transport proteins that facilitate ...

WO2009052286A1 - Grading, staging, and prognosing cancer using ...

https://patents.google.com/patent/WO2009052286A1/en
Osteopontin-b lacks exon 5 and osteopontin-c lacks exon 4. SUMMARY. While the acquisition of invasiveness is a critical step in early stage breast carcinomas ( ...

How to interpret your lab ... - Houston Thyroid & Endocrine Specialists

https://sites.google.com/houstonendocrine.com/website/patientportal/results-interpretation
That means that 5% of our healthy patients fall outside of the ... Thus an abnormal test does not necessarily mean that there is something wrong with you.

US10236078B2 - Methods for processing or analyzing a sample of ...

https://patents.google.com/patent/US10236078B2/en
... level is indicative of the presence of thyroid cancer in the biological sample. ... does not classify said sample of tissue as positive for said thyroid cancer.

US20080213805A1 - Method for Distinguishing Follicular Thyroid ...

https://patents.google.com/patent/US20080213805A1/en
... would be one means of improving the accuracy of diagnoses made from FNA. ... Clorf24 was described as a candidate marker for renal tumor, especially in early- ...

US10357494B2 - Combination therapy comprising varlitinib and an ...

https://patents.google.com/patent/US10357494B2/en
Stage IV—This is the most advanced stage of ovarian cancer. Growth of the ... cancer, thyroid cancer, skin cancer, renal cancer, and oesophagus cancer.

WO2012085948A1 - Genetic variants useful for risk assessment of ...

https://patents.google.com/patent/WO2012085948A1/en
... stage, thyroid cancer is a well manageable disease with a ... This means that a patient diagnosed with thyroid cancer and carrying such risk alleles would ...

US20120282177A1 - ROR1 as Therapeutic and Diagnostic Target ...

https://patents.google.com/patent/US20120282177A1/en
Stage grouping for medullary thyroid carcinoma in people of any age is the ... Relative 5-year survival rates by stage for papillary thyroid cancer are: Stage ...

US8637554B2 - Methods for treating thyroid cancer - Google Patents

https://patents.google.com/patent/US8637554B2/en
4 shows Different Responses in patients on sorafenib with stably suppressed TSH. While patient 5 reached and maintained a PR in tumor size, serum thyroglobulin ...

US20160208337A1 - Quantification of lamin c and lamin a for tumor ...

https://patents.google.com/patent/US20160208337A1/en
7B shows the ratios in lung, ovary, thyroid, and prostate cancers. The mean normalized expression levels of Lamin A and Lamin C mRNA was calculated using Q-Gene ...

US8834877B2 - Anti-folate receptor alpha antibodies and uses ...

https://patents.google.com/patent/US8834877B2/en
... thyroid cancer that does not express FRα, such as medullary carcinoma. In ... definition of a positive result (±5% tumor cell membrane staining).

CA3210972A1 - Biomarkers for the diagnosis of breast cancer ...

https://patents.google.com/patent/CA3210972A1/en
... stage 2, stage 3, stage 4 and stage 5 of breast cancer. [0026] The methods ... cancer at a stage when treatment would have the greatest effect. Early ...

WO2017037300A1 - Varlitinib for use in the treatment of resistant or ...

https://patents.google.com/patent/WO2017037300A1/en
Stage IV - This is the most advanced stage of ovarian cancer. Growth of the ... Thyroid cancer as employed herein refers to cancer of the thyroid ...